One Medical Radioisotopes Start Routine Production of Molybdenum-99 at University of Missouri Research Reactor
According to some related reported that MADISON, WI--(Marketwired-August 31, 2015) – one medical radioisotopes LLC has received approval to begin routine production of molybdenum-99 (Mo-99) at theUniversity of Missouri Research Reactor (MURR) facility in Columbia, Missouri. The company will now be able to regularly operate its proprietary aliquoting system at the MURR site to fill source vessels with Mo-99, enabling the company to establish a weekly production schedule and increase its output of the vital medical radioisotope.
This transitioning Mo-99 line at MURR from a development process to a routine production process is another significant step toward establishment of a domestic source of Mo-99. The company can immediately boost its output at MURR to as much as 200 6-day curies per process; a curie (Ci) is a unit of radioactivity and 6-day Ci is the number of curies present in a shipment of Mo-99 six days after it leaves the producer's facility. The medical radioisotopes also will be able to further increase its Mo-99 output at MURR after the production process receives final approval from the U.S.
Molybdenum Manufacturer & Supplier: Chinatungsten Online - http://news.molybdenum.com.cn Tel.: 86 592 5129696; Fax: 86 592 5129797 Email: sales@chinatungsten.com Tungsten & Molybdenum Information Bank: http://i.chinatungsten.com Tungsten News & Tungsten Prices, 3G Version: http://3g.chinatungsten.com Molybdenum News & Molybdenum Price: http://news.molybdenum.com.cn
If you need any more details of the above news and/or products, please visit Chinatungsten Online, or contact us directly. Disclaimer: The article is only reflecting the opinions of the author. We have no responsibility to prove the originality and authenticity of the content, words and/or pictures. You readers should just take it as reference and check the details by yourselves. And the content is not a suggestion for investment decision. The investor takes his or her own risks if he or she operates accordingly. If you have any dissent about the contents above, please contact the relevant author, or the webmaster. We will try our best to assist the dealing of the related issues. Thanks for your visit and cooperation. |